Diffusible factors and cancer cells
作者： Marco Archetti
DOI:
关键词:
摘要: The present invention relates to modified cancer cells that are defective in the production of diffusible factors (e.g. growth factors), and use such for impairing a population human cells, particular wherein is neoplasm, tumour or cancer. preferably comprises step modifying by deleting endogenous genes code (or affect of), promote cell survival proliferation.
lens.org参考文章(139)
Kenneth L. Cohen, S. Peter Nissley, The serum half-life of somatomedin activity: evidence for growth hormone dependence. European Journal of Endocrinology. ,vol. 83, pp. 243- 258 ,(1976) , 10.1530/ACTA.0.0830243
T-K Ito, G Ishii, H Chiba, A Ochiai, The VEGF angiogenic switch of fibroblasts is regulated by MMP-7 from cancer cells. Oncogene. ,vol. 26, pp. 7194- 7203 ,(2007) , 10.1038/SJ.ONC.1210535
Shanna Arnold, Emilia Mira, Sabeeha Muneer, Grzegorz Korpanty, Adam W. Beck, Shane E. Holloway, Santos Mañes, Rolf A. Brekken, Forced Expression of MMP9 Rescues the Loss of Angiogenesis and Abrogates Metastasis of Pancreatic Tumors Triggered by the Absence of Host SPARC Experimental Biology and Medicine. ,vol. 233, pp. 860- 873 ,(2008) , 10.3181/0801-RM-12
T.-L. Wang, L. A. Diaz, K. Romans, A. Bardelli, S. Saha, G. Galizia, M. Choti, R. Donehower, G. Parmigiani, I.-M. Shih, C. Iacobuzio-Donahue, K. W. Kinzler, B. Vogelstein, C. Lengauer, V. E. Velculescu, Digital karyotyping identifies thymidylate synthase amplification as a mechanism of resistance to 5-fluorouracil in metastatic colorectal cancer patients. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 101, pp. 3089- 3094 ,(2004) , 10.1073/PNAS.0308716101
R.L. Hintz, Role of growth-hormone and insulin-like growth-factor-binding proteins. Hormone Research in Paediatrics. ,vol. 33, pp. 105- 110 ,(1990) , 10.1159/000181492
Jeffrey C Miller, Siyuan Tan, Guijuan Qiao, Kyle A Barlow, Jianbin Wang, Danny F Xia, Xiangdong Meng, David E Paschon, Elo Leung, Sarah J Hinkley, Gladys P Dulay, Kevin L Hua, Irina Ankoudinova, Gregory J Cost, Fyodor D Urnov, H Steve Zhang, Michael C Holmes, Lei Zhang, Philip D Gregory, Edward J Rebar, A TALE nuclease architecture for efficient genome editing Nature Biotechnology. ,vol. 29, pp. 143- 148 ,(2011) , 10.1038/NBT.1755
P. W. Gray, K. Barrett, D. Chantry, M. Turner, M. Feldmann, Cloning of human tumor necrosis factor (TNF) receptor cDNA and expression of recombinant soluble TNF-binding protein. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 7380- 7384 ,(1990) , 10.1073/PNAS.87.19.7380
John W. Pepper, Defeating pathogen drug resistance: guidance from evolutionary theory. Evolution. ,vol. 62, pp. 3185- 3191 ,(2008) , 10.1111/J.1558-5646.2008.00525.X
Elianna M. Amin, Sebastian Oltean, Jing Hua, Melissa V.R. Gammons, Maryam Hamdollah-Zadeh, Gavin I. Welsh, Man-Kim Cheung, Lan Ni, Satoru Kase, Emma S. Rennel, Kirsty E. Symonds, Dawid G. Nowak, Brigitte Royer-Pokora, Moin A. Saleem, Masatoshi Hagiwara, Valérie A. Schumacher, Steven J. Harper, David R. Hinton, David O. Bates, Michael R. Ladomery, WT1 Mutants Reveal SRPK1 to Be a Downstream Angiogenesis Target by Altering VEGF Splicing Cancer Cell. ,vol. 20, pp. 768- 780 ,(2011) , 10.1016/J.CCR.2011.10.016
J Zapf, C Hauri, M Waldvogel, E R Froesch, Acute metabolic effects and half-lives of intravenously administered insulinlike growth factors I and II in normal and hypophysectomized rats. Journal of Clinical Investigation. ,vol. 77, pp. 1768- 1775 ,(1986) , 10.1172/JCI112500